Lombard Medical, Inc., a medical technology company, develops, manufactures, and markets endovascular stent-grafts for the repair of aortic aneurysms in the United States, the United Kingdom, Germany, Japan, and internationally. Its principal product is Aorfix, which is an endovascular stent-graft for the treatment of abdominal aortic aneurysms (AAAs) with angulation at the neck of the aneurysm of...
Lombard Medical reported revenue of $12.17 million for fiscal year 2016, down 19.5% from fiscal year 2015, and net income of -$31.04 million. Its market capitalization was $2,795 as of October 6, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2016; market data as of October 6, 2026.
No profile data available.